CN105111228A - Chiral phosphoric acid with 5,5'-bitetralone skeleton and preparation method thereof - Google Patents
Chiral phosphoric acid with 5,5'-bitetralone skeleton and preparation method thereof Download PDFInfo
- Publication number
- CN105111228A CN105111228A CN201510543647.3A CN201510543647A CN105111228A CN 105111228 A CN105111228 A CN 105111228A CN 201510543647 A CN201510543647 A CN 201510543647A CN 105111228 A CN105111228 A CN 105111228A
- Authority
- CN
- China
- Prior art keywords
- tetralone
- formula
- phosphoric acid
- diphenol
- disubstituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 title claims abstract description 78
- 229910000147 aluminium phosphate Inorganic materials 0.000 title claims abstract description 50
- 238000002360 preparation method Methods 0.000 title abstract description 16
- QQALXKJBIRREBW-UHFFFAOYSA-N 5-(5-oxo-7,8-dihydro-6H-naphthalen-1-yl)-3,4-dihydro-2H-naphthalen-1-one Chemical group C1(CCCC=2C(=CC=CC1=2)C=1C=2CCCC(C=2C=CC=1)=O)=O QQALXKJBIRREBW-UHFFFAOYSA-N 0.000 title 1
- 238000000034 method Methods 0.000 claims abstract description 52
- 239000003054 catalyst Substances 0.000 claims abstract description 23
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical group ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 42
- 150000001875 compounds Chemical class 0.000 claims description 30
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 27
- HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 claims description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 claims description 20
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 18
- 239000007800 oxidant agent Substances 0.000 claims description 18
- 238000010898 silica gel chromatography Methods 0.000 claims description 18
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 claims description 16
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 14
- 238000007254 oxidation reaction Methods 0.000 claims description 13
- -1 3,5-bis(trifluoromethyl)phenyl Chemical group 0.000 claims description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical group CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 10
- 125000003118 aryl group Chemical group 0.000 claims description 10
- 230000001590 oxidative effect Effects 0.000 claims description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 7
- 239000003480 eluent Substances 0.000 claims description 7
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical group [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 claims description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- 230000007062 hydrolysis Effects 0.000 claims description 6
- 238000006460 hydrolysis reaction Methods 0.000 claims description 6
- 239000003960 organic solvent Substances 0.000 claims description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 5
- 229960000583 acetic acid Drugs 0.000 claims description 5
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 claims description 5
- 238000005859 coupling reaction Methods 0.000 claims description 5
- 239000012362 glacial acetic acid Substances 0.000 claims description 5
- 125000001624 naphthyl group Chemical group 0.000 claims description 5
- 125000001792 phenanthrenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 claims description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 229910001882 dioxygen Inorganic materials 0.000 claims description 4
- HTJWUNNIRKDDIV-UHFFFAOYSA-N bis(1-adamantyl)-butylphosphane Chemical compound C1C(C2)CC(C3)CC2CC13P(CCCC)C1(C2)CC(C3)CC2CC3C1 HTJWUNNIRKDDIV-UHFFFAOYSA-N 0.000 claims description 3
- 229960002089 ferrous chloride Drugs 0.000 claims description 3
- NMCUIPGRVMDVDB-UHFFFAOYSA-L iron dichloride Chemical compound Cl[Fe]Cl NMCUIPGRVMDVDB-UHFFFAOYSA-L 0.000 claims description 3
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 3
- 150000003376 silicon Chemical class 0.000 claims description 3
- 229910052710 silicon Inorganic materials 0.000 claims description 3
- 239000010703 silicon Substances 0.000 claims description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 2
- 230000009471 action Effects 0.000 claims description 2
- 238000005658 halogenation reaction Methods 0.000 claims description 2
- 125000003107 substituted aryl group Chemical class 0.000 claims description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims 2
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 claims 1
- LVEYOSJUKRVCCF-UHFFFAOYSA-N 1,3-bis(diphenylphosphino)propane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)CCCP(C=1C=CC=CC=1)C1=CC=CC=C1 LVEYOSJUKRVCCF-UHFFFAOYSA-N 0.000 claims 1
- 229910021595 Copper(I) iodide Inorganic materials 0.000 claims 1
- 229910021586 Nickel(II) chloride Inorganic materials 0.000 claims 1
- DLIJPAHLBJIQHE-UHFFFAOYSA-N butylphosphane Chemical compound CCCCP DLIJPAHLBJIQHE-UHFFFAOYSA-N 0.000 claims 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 claims 1
- 229910000024 caesium carbonate Inorganic materials 0.000 claims 1
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 claims 1
- GPAYUJZHTULNBE-UHFFFAOYSA-N diphenylphosphine Chemical compound C=1C=CC=CC=1PC1=CC=CC=C1 GPAYUJZHTULNBE-UHFFFAOYSA-N 0.000 claims 1
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 claims 1
- QMMRZOWCJAIUJA-UHFFFAOYSA-L nickel dichloride Chemical compound Cl[Ni]Cl QMMRZOWCJAIUJA-UHFFFAOYSA-L 0.000 claims 1
- ZBRJXVVKPBZPAN-UHFFFAOYSA-L nickel(2+);triphenylphosphane;dichloride Chemical compound [Cl-].[Cl-].[Ni+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 ZBRJXVVKPBZPAN-UHFFFAOYSA-L 0.000 claims 1
- 229910000160 potassium phosphate Inorganic materials 0.000 claims 1
- 235000011009 potassium phosphates Nutrition 0.000 claims 1
- VNFWTIYUKDMAOP-UHFFFAOYSA-N sphos Chemical compound COC1=CC=CC(OC)=C1C1=CC=CC=C1P(C1CCCCC1)C1CCCCC1 VNFWTIYUKDMAOP-UHFFFAOYSA-N 0.000 claims 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 abstract description 6
- PPTXVXKCQZKFBN-UHFFFAOYSA-N (S)-(-)-1,1'-Bi-2-naphthol Chemical compound C1=CC=C2C(C3=C4C=CC=CC4=CC=C3O)=C(O)C=CC2=C1 PPTXVXKCQZKFBN-UHFFFAOYSA-N 0.000 abstract description 5
- 230000015572 biosynthetic process Effects 0.000 abstract description 4
- 230000008569 process Effects 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 238000006053 organic reaction Methods 0.000 abstract 1
- 230000009257 reactivity Effects 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 38
- 229960004838 phosphoric acid Drugs 0.000 description 30
- 235000011007 phosphoric acid Nutrition 0.000 description 22
- 238000006243 chemical reaction Methods 0.000 description 21
- 239000000243 solution Substances 0.000 description 16
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 14
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 14
- 235000019439 ethyl acetate Nutrition 0.000 description 13
- 238000002844 melting Methods 0.000 description 11
- 230000008018 melting Effects 0.000 description 11
- 239000012141 concentrate Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- 239000003208 petroleum Substances 0.000 description 8
- 238000004467 single crystal X-ray diffraction Methods 0.000 description 8
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 7
- 229910052786 argon Inorganic materials 0.000 description 7
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- OKKJLVBELUTLKV-VMNATFBRSA-N methanol-d1 Chemical compound [2H]OC OKKJLVBELUTLKV-VMNATFBRSA-N 0.000 description 6
- 0 *c(cc(CCCC1)c1c1-c2c(CCCC3)c3cc(*)c2O)c1O Chemical compound *c(cc(CCCC1)c1c1-c2c(CCCC3)c3cc(*)c2O)c1O 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 239000007832 Na2SO4 Substances 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 description 4
- 235000011152 sodium sulphate Nutrition 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000013256 coordination polymer Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000009901 transfer hydrogenation reaction Methods 0.000 description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 3
- FSEXLNMNADBYJU-UHFFFAOYSA-N 2-phenylquinoline Chemical compound C1=CC=CC=C1C1=CC=C(C=CC=C2)C2=N1 FSEXLNMNADBYJU-UHFFFAOYSA-N 0.000 description 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 238000005761 Biginelli synthesis reaction Methods 0.000 description 2
- 238000005698 Diels-Alder reaction Methods 0.000 description 2
- 238000005727 Friedel-Crafts reaction Methods 0.000 description 2
- 238000006683 Mannich reaction Methods 0.000 description 2
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 125000006575 electron-withdrawing group Chemical group 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000012265 solid product Substances 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- YXEFFHITYOBLCN-UHFFFAOYSA-N 1-adamantyl(butyl)phosphane Chemical compound C1C(C2)CC3CC2CC1(PCCCC)C3 YXEFFHITYOBLCN-UHFFFAOYSA-N 0.000 description 1
- LFWYNEFAZONJCX-UHFFFAOYSA-N Oc(c(-c1c(CCCC2=O)c2ccc1O)c1CCC2)ccc1C2=O Chemical compound Oc(c(-c1c(CCCC2=O)c2ccc1O)c1CCC2)ccc1C2=O LFWYNEFAZONJCX-UHFFFAOYSA-N 0.000 description 1
- UTXIFKBYNJRJPH-UHFFFAOYSA-N Oc(ccc1c2CCCC1)c2-c1c(CCCC2)c2ccc1O Chemical compound Oc(ccc1c2CCCC1)c2-c1c(CCCC2)c2ccc1O UTXIFKBYNJRJPH-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- BPTABBGLHGBJQR-UHFFFAOYSA-N [3,5-bis(trifluoromethyl)phenyl]boronic acid Chemical compound OB(O)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 BPTABBGLHGBJQR-UHFFFAOYSA-N 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000011914 asymmetric synthesis Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940117975 chromium trioxide Drugs 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N chromium trioxide Inorganic materials O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- GAMDZJFZMJECOS-UHFFFAOYSA-N chromium(6+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Cr+6] GAMDZJFZMJECOS-UHFFFAOYSA-N 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- DMSZORWOGDLWGN-UHFFFAOYSA-N ctk1a3526 Chemical compound NP(N)(N)=O DMSZORWOGDLWGN-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- ZMLOGBUGDUAKPT-UHFFFAOYSA-N n-diaminophosphoryl-1,1,1-trifluoromethanesulfonamide Chemical compound NP(N)(=O)NS(=O)(=O)C(F)(F)F ZMLOGBUGDUAKPT-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- QJDUDPQVDAASMV-UHFFFAOYSA-M sodium;ethanethiolate Chemical compound [Na+].CC[S-] QJDUDPQVDAASMV-UHFFFAOYSA-M 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明属于有机化学合成技术领域。本发明公开了5,5ˊ-联四氢萘酮这一手性骨架,和一种具有5,5ˊ-联四氢萘酮骨架的手性磷酸,以及基于5,5ˊ-联四氢萘酮-6,6ˊ-二酚及其取代物制备该手性磷酸的方法。这类磷酸既保留了传统的基于BINOL和H8-BINOL的手性磷酸的对映选择性好的优点,在一些有机反应中表现出同样优秀的对映选择性;又克服了其催化活性较低的缺点,表现出比传统磷酸更强的反应活性。并且制备方法中的原料及催化剂廉价易得,合成路线较短,工艺简单,条件温和,具有工业化潜力。
The invention belongs to the technical field of organic chemical synthesis. The invention discloses a chiral skeleton of 5,5'-tetralone, a chiral phosphoric acid with a 5,5'-tetralone skeleton, and a chiral phosphoric acid based on 5,5'-tetralone-6 , A method for preparing the chiral phosphoric acid from 6'-diphenol and its substituents. This kind of phosphoric acid not only retains the advantages of good enantioselectivity of traditional chiral phosphoric acid based on BINOL and H 8 -BINOL, but also shows the same excellent enantioselectivity in some organic reactions; Low disadvantage, showing stronger reactivity than traditional phosphoric acid. In addition, the raw materials and catalysts in the preparation method are cheap and easy to obtain, the synthesis route is short, the process is simple, the conditions are mild, and the method has industrialization potential.
Description
技术领域 technical field
本发明属于有机化学合成技术领域,具体涉及一种具有5,5'-联四氢萘酮骨架的手性磷酸,以及基于5,5'-联四氢萘酮-6,6'-二酚及其取代物制备该手性磷酸的方法,以及制备过程中涉及的中间体。 The invention belongs to the technical field of organic chemical synthesis, in particular to a chiral phosphoric acid with a 5,5'-tetralone skeleton, and a 5,5'-tetralone-6,6'-diphenol-based A method for preparing the chiral phosphoric acid and its substitutes, as well as intermediates involved in the preparation process.
背景技术 Background technique
新颖手性催化剂的发展是不对称合成中一个较为活跃的领域。2004年Akiyama和Terada两个小组独立发现的基于BINOL的手性联萘磷酸催化剂(phosphoricacid,Angew.Chem.Int.Ed.2004,43,1566;J.Am.Chem.Soc.2004,126,5356),已被广泛应用于许多有机转化。手性磷酸催化的反应具有多种活化模式(Chem.Rev.2014,114,9047),取得了优秀的对映选择性,但大多数反应时间较长,催化剂用量较大(5%~20%),一定程度上限制了手性有机磷酸在规模化合成及工业生产上的应用。 The development of novel chiral catalysts is an active field in asymmetric synthesis. In 2004, two groups of Akiyama and Terada independently discovered the BINOL-based chiral binaphthylphosphoric acid catalyst (phosphoricacid, Angew.Chem.Int.Ed.2004,43,1566; J.Am.Chem.Soc.2004,126,5356 ), which have been widely used in many organic transformations. The reaction catalyzed by chiral phosphoric acid has a variety of activation modes (Chem.Rev.2014, 114, 9047), and has achieved excellent enantioselectivity, but most of the reaction time is long and the amount of catalyst is large (5%-20% ), which to some extent limits the application of chiral organophosphoric acid in large-scale synthesis and industrial production.
一种增强磷酸酸性的方法是制成磷酰胺,如N-triflylphosphoramide(J.Am.Chem.Soc.2006,128,9626),能明显增加催化活性,但在大多数反应中,对映选择性明显降低(J.Am.Chem.Soc.2013,135,6142)。另一种增强酸性的方法是在联萘磷酸的3,3'-位(酚羟基邻位)引入吸电子基团,如3,5-二(三氟甲基)苯基,但这本身会不可避免的改变3,3'-位取代基的体积,从而影响对映选择性(Org.Lett.2010,12,4604)。然而,在联萘磷酸的5,5'-位(酚羟基对位)引入吸电子基团的方法,至今无文献报道。 One way to enhance the acidity of phosphoric acid is to make phosphoramide, such as N-triflylphosphoramide (J.Am.Chem.Soc.2006,128,9626), which can significantly increase the catalytic activity, but in most reactions, enantioselectivity Significantly lower (J.Am.Chem.Soc.2013,135,6142). Another way to enhance the acidity is to introduce an electron-withdrawing group such as 3,5-bis(trifluoromethyl)phenyl at the 3,3'-position (ortho to the phenolic hydroxyl group) of binaphthylphosphonic acid, but this in itself would It inevitably changes the volume of the 3,3'-position substituent, thereby affecting the enantioselectivity (Org. Lett. 2010, 12, 4604). However, there is no literature report on the method of introducing an electron-withdrawing group at the 5,5'-position (para-position of the phenolic hydroxyl group) of binaphthylphosphonic acid.
本发明公开了5,5'-联四氢萘酮这一手性骨架,和一种具有5,5'-联四氢萘酮手性骨架的手性磷酸,以及基于5,5'-联四氢萘酮-6,6’-二酚及其取代物制备该手性磷酸的方法。这类磷酸既保留了传统的基于BINOL和H8-BINOL的有机手性磷酸的对映选择性好的优点,又克服了其催化活性较低的缺点。 The invention discloses a chiral skeleton of 5,5'-tetralone, a chiral phosphoric acid having a chiral skeleton of 5,5'-tetralone, and a chiral phosphoric acid based on 5,5'-tetralone Hydronaphthalene-6,6'-diol and its substitutes are a method for preparing the chiral phosphoric acid. This kind of phosphoric acid not only retains the advantages of good enantioselectivity of traditional organic chiral phosphoric acids based on BINOL and H 8 -BINOL, but also overcomes the disadvantage of low catalytic activity.
发明内容 Contents of the invention
1.要解决的技术问题 1. Technical problems to be solved
为解决传统的有机手性磷酸催化剂活性较低的缺点,本发明公开了一类全新设计的手机磷酸催化剂的结构及其制备方法。 In order to solve the shortcoming of low activity of traditional organic chiral phosphoric acid catalysts, the invention discloses a structure of a newly designed mobile phone phosphoric acid catalyst and a preparation method thereof.
2.技术方案 2. Technical solution
本发明的目的是提供一种5,5'-联四氢萘酮的全新手性骨架; The purpose of the present invention is to provide a brand-new chiral skeleton of 5,5'-tetralone;
本发明的另一目的是提供一种具有5,5'-联四氢萘酮骨架的手性磷酸; Another object of the present invention is to provide a chiral phosphoric acid having a 5,5'-binethralone skeleton;
本发明的另一目的是提供基于5,5'-联四氢萘酮-6,6'-二酚制备手性磷酸的方法。 Another object of the present invention is to provide a method for preparing chiral phosphoric acid based on 5,5'-binetralone-6,6'-diol.
本发明是具有(I)~(V)所示通式的化合物: The present invention is a compound having general formula shown in (I)~(V):
式中:R选自H、Cl、Br、I、C6~C19的烷基、取代的硅基、取代的芳基或者共轭芳基,所述的共轭芳基为萘基、蒽基、菲基;R1选自H、Ac、Boc、Bz、MOM、C1~C8的烷基;X选自Cl、Br或I。 In the formula: R is selected from H, Cl, Br, I, C6-C19 alkyl, substituted silicon, substituted aryl or conjugated aryl, and the conjugated aryl is naphthyl, anthracenyl, Phenanthrene group; R 1 is selected from H, Ac, Boc, Bz, MOM, C1~C8 alkyl; X is selected from Cl, Br or I.
式(I)所示化合物属于手性有机磷酸。跟传统的相应的基于BINOL或H8-BINOL的磷酸相比,分子结构改变不大,保留了同样优秀的手性诱导能力;但酸性更强,所以又克服了传统磷酸催化剂用量大、反应时间较长等缺点。在Mannich反应、Biginelli反应、Friedel-Crafts反应、Diels-Alder反应、转移氢化反应等反应中均取得了优秀的对映选择性和更强的催化活性。 The compound represented by formula (I) belongs to chiral organophosphoric acid. Compared with the corresponding traditional phosphoric acid based on BINOL or H 8 -BINOL, the molecular structure has not changed much, and the same excellent chiral induction ability is retained; but the acidity is stronger, so it overcomes the traditional phosphoric acid catalyst consumption and reaction time. long and other disadvantages. It has achieved excellent enantioselectivity and stronger catalytic activity in Mannich reaction, Biginelli reaction, Friedel-Crafts reaction, Diels-Alder reaction, transfer hydrogenation reaction and other reactions.
式(I)~(V)所示化合物结构具有轴手性,所以每个化合物都具有两个对映异构体,一个是R型,另一个是S型,该两个对映异构体的等量混合物则成为外消旋体。R型、S型和外消旋体具有相同的化学结构通式,但具有不同的立体结构和旋光性能。因此,本发明所说的具有5,5'-联四氢萘酮骨架的手性磷酸,及其合成过程涉及的相应中间体,实际上包含R型、S型和外消旋体。 The compound structures shown in formulas (I)~(V) have axial chirality, so each compound has two enantiomers, one is R type, and the other is S type, the two enantiomers The mixture of equal amounts becomes a racemate. R-type, S-type and racemate have the same general chemical structure, but have different stereostructures and optical properties. Therefore, the chiral phosphoric acid with 5,5'-tetralone skeleton mentioned in the present invention and the corresponding intermediates involved in the synthesis process actually include R-type, S-type and racemate.
本发明提供的式(I)所示化合物的制备方法,包括如下步骤: The preparation method of the compound shown in the formula (I) provided by the invention comprises the following steps:
采用方法一,则步骤为: Using Method 1, the steps are:
(1)H8-BINOL在有机溶剂(或含水)中,经过适当催化剂作用,适当的温度和时间的氧化反应,得到式(Ⅱ)所示5,5'-联四氢萘酮-6,6'-二酚; (1) H 8 -BINOL is oxidized in an organic solvent (or containing water) through an appropriate catalyst, appropriate temperature and time to obtain 5,5'-tetralone-6 represented by formula (II), 6'-diphenol;
(2)式(II)所示5,5'-联四氢萘酮-6,6'-二酚,经过卤化反应,得到式(III)所示7,7'-二卤-5,5'-联四氢萘酮-6,6'-二酚; (2) 5,5'-tetralone-6,6'-diol represented by formula (II) undergoes a halogenation reaction to obtain 7,7'-dihalo-5,5 represented by formula (III) '-tetralone-6,6'-diol;
(3)式(III)所示7,7'-二卤-5,5'-联四氢萘酮-6,6'-二酚,经过偶联反应,得到式(IV)所示7,7'-二取代-5,5'-联四氢萘酮-6,6'-二酚; (3) 7,7'-dihalo-5,5'-tetralone-6,6'-diol represented by formula (III), undergoes a coupling reaction to obtain 7 represented by formula (IV), 7'-disubstituted-5,5'-tetralone-6,6'-diol;
(4)式(IV)所示7,7'-二取代-5,5'-联四氢萘酮-6,6'-二酚,与三氯氧磷在碱性条件中反应后,再经过水解,得到式(I)所示7,7'-二取代-5,5'-联四氢萘酮-6,6'-二酚-磷酸; (4) 7,7'-disubstituted-5,5'-tetralone-6,6'-diphenol shown in formula (IV), after reacting with phosphorus oxychloride in alkaline conditions, then After hydrolysis, the 7,7'-disubstituted-5,5'-binethalone-6,6'-diphenol-phosphoric acid represented by the formula (I) is obtained;
(5)采用硅胶柱层析对制备的式(I)的化合物进行提纯; (5) Purify the compound of formula (I) prepared by silica gel column chromatography;
或采用方法二,则步骤为: Or use method 2, the steps are:
(1)式(V)所示3,3'-二取代-H8-BINOL,有机溶剂(或含水)中,经过适当催化剂作用,适当的温度和时间的氧化反应,得到式(IV)所示7,7'-二取代-5,5'-联四氢萘酮-6,6'-二酚; (1) 3,3'-disubstituted-H 8 -BINOL represented by formula (V), in an organic solvent (or containing water), through an oxidation reaction with a suitable catalyst, a suitable temperature and time, to obtain the formula (IV) Represents 7,7'-disubstituted-5,5'-tetralone-6,6'-diol;
(2)式(IV)所示7,7'-二取代-5,5'-联四氢萘酮-6,6'-二酚,与三氯氧磷在碱性条件中反应后,再经过水解,得到式(I)所示7,7'-二取代-5,5'-联四氢萘酮-6,6'-二酚-磷酸; (2) 7,7'-disubstituted-5,5'-tetralone-6,6'-diphenol shown in formula (IV), after reacting with phosphorus oxychloride in alkaline conditions, then After hydrolysis, the 7,7'-disubstituted-5,5'-binethalone-6,6'-diphenol-phosphoric acid represented by the formula (I) is obtained;
(3)采用硅胶柱层析对制备的式(I)的化合物进行提纯; (3) Purify the compound of formula (I) prepared by silica gel column chromatography;
或采用方法三,则步骤为: Or use method three, the steps are:
(1)式(VI)所示3,3'-二取代-H8-联萘酚-2,2'-二氧化合物,有机溶剂(或含水)中,经过适当催化剂作用,适当的温度和时间的氧化反应,得到式(VII)所示7,7'-二取代-5,5'-联四氢萘酮-6,6'-二氧化合物; (1) 3,3'-disubstituted-H 8 -binaphthol-2,2'-dioxygen compound represented by formula (VI), in organic solvent (or containing water), after proper catalyst action, proper temperature and Oxidation reaction of time to obtain 7,7'-disubstituted-5,5'-binethalone-6,6'-dioxy compound shown in formula (VII);
(2)(VII)所示7,7'-二取代-5,5'-联四氢萘酮-6,6'-二氧化合物,经过脱保护,得到式(IV)所示7,7'-二取代-5,5'-联四氢萘酮-6,6'-二酚; (2) The 7,7'-disubstituted-5,5'-tetralone-6,6'-dioxy compound shown in (VII) is deprotected to obtain the 7,7 shown in the formula (IV). '-Disubstituted-5,5'-tetralone-6,6'-diol;
(3)式(IV)所示7,7'-二取代-5,5'-联四氢萘酮-6,6'-二酚,与三氯氧磷在碱性条件中反应后,再经过水解,得到式(I)所示7,7'-二取代-5,5'-联四氢萘酮-6,6'-二酚-磷酸; (3) 7,7'-disubstituted-5,5'-tetralone-6,6'-diphenol shown in formula (IV), after reacting with phosphorus oxychloride in alkaline conditions, then After hydrolysis, the 7,7'-disubstituted-5,5'-binethalone-6,6'-diphenol-phosphoric acid represented by the formula (I) is obtained;
(4)采用硅胶柱层析对制备的式(I)的化合物进行提纯。 (4) Purify the prepared compound of formula (I) by silica gel column chromatography.
其中: in:
方法一步骤中X可为Cl,Br,I,优选Br;R为取代的苯基或者共轭芳基,所述的共轭芳基为萘基、蒽基、菲基;方法二步骤中R为取代的硅基,优选三苯基硅基;方法三步骤中R1为Ac、Boc、Bz、MOM、C1~C8的烷基,优选Me; In the first step of the method, X can be Cl, Br, I, preferably Br; R is a substituted phenyl group or a conjugated aryl group, and the conjugated aryl group is naphthyl, anthracenyl, or phenanthrenyl; in the second step of the method, R is a substituted silicon group, preferably a triphenylsilyl group; in the three steps of the method, R 1 is an alkyl group of Ac, Boc, Bz, MOM, C1-C8, preferably Me;
方法一步骤(1)的氧化反应所使用的氧化剂为2,3-二氯-5,6-二氰基-1,4-苯醌(DDQ),所述H8-BINOL和氧化剂的摩尔比为1:(4~6),优选1:4;方法一步骤(3)的偶联反应条件为:催化剂为醋酸钯+二(金刚烷基)正丁基膦,碱为碳酸钾,溶剂为甲苯+乙醇、或乙二醇二甲醚+水。 The oxidizing agent used in the oxidation reaction of method one step (1) is 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ), and the molar ratio of the H 8 -BINOL to the oxidizing agent is It is 1:(4~6), preferably 1:4; The coupling reaction condition of method one step (3) is: catalyst is palladium acetate+two (adamantyl) n-butylphosphine, alkali is potassium carbonate, and solvent is Toluene + ethanol, or ethylene glycol dimethyl ether + water.
方法二步骤(1)的氧化反应中氧化剂为DDQ,加入氯化亚铁催化剂,所述式(V)化合物、氧化剂和催化剂的摩尔比为1:(4~6):(0.05~0.2),优选3.6:21.6:0.73。 In the oxidation reaction of method two steps (1), the oxidizing agent is DDQ, and a ferrous chloride catalyst is added, and the molar ratio of the compound of formula (V), the oxidizing agent and the catalyst is 1:(4~6):(0.05~0.2), Preferably 3.6:21.6:0.73.
方法三步骤(1)的氧化反应中氧化剂为CrO3,所述式(VI)化合物和氧化剂的摩尔比为1:(4~8),优选1:6;溶剂为冰醋酸+水,体积比(2~4):1,优选3:1。 In the oxidation reaction of the third step (1) of the method, the oxidant is CrO 3 , the molar ratio of the compound of formula (VI) to the oxidant is 1:(4-8), preferably 1:6; the solvent is glacial acetic acid+water, the volume ratio (2~4):1, preferably 3:1.
方法一的步骤(5)、方法二的步骤(3)、方法三的步骤(4)所用的硅胶柱层析的条件均为:淋洗剂为二氯甲烷:甲醇,体积比40:1~10:1,含产物组份的淋洗剂溶液合并后,依次经过1mol/L稀盐酸洗涤、无水Na2SO4干燥、抽滤、浓缩。 The conditions of the silica gel column chromatography used in step (5) of method one, step (3) of method two and step (4) of method three are: eluting agent is dichloromethane:methanol, volume ratio 40:1~ 10:1, after the eluent solutions containing product components are combined, they are washed with 1mol/L dilute hydrochloric acid, dried with anhydrous Na 2 SO 4 , suction filtered, and concentrated.
3.有益效果 3. Beneficial effect
本发明提供了一种全新的5,5'-联四氢萘酮手性骨架和一种具有5,5'-联四氢萘酮骨架的手性磷酸。本发明还提供了一种高效制备基于5,5'-联四氢萘酮-6,6'-二酚的手性磷酸的方法。该方法原料不贵,步骤短,反应条件温和,不会消旋,操作简便,产率较高,适合工业上大规模合成。所制备的手性磷酸可以用于Mannich反应、Biginelli反应、Friedel-Crafts反应、Diels-Alder反应、转移氢化反应等反应的催化剂。例如,应用于2-苯基喹啉与Hantzsch乙酯的转移氢化反应:0.2mol%催化剂用量,苯做溶剂,室温下反应11小时,可取得定量产率和98%的对映体过量(ee);并且相同条件下,比相应的H8-BINOL和BINOL骨架的磷酸反应更快,增幅分别高达35%和20%的转化率。 The invention provides a brand new chiral skeleton of 5,5'-tetralone and a chiral phosphoric acid with the skeleton of 5,5'-tetralone. The invention also provides a method for efficiently preparing chiral phosphoric acid based on 5,5'-binetralone-6,6'-diol. The method has the advantages of inexpensive raw materials, short steps, mild reaction conditions, no racemization, simple operation and high yield, and is suitable for industrial large-scale synthesis. The prepared chiral phosphoric acid can be used as a catalyst for Mannich reaction, Biginelli reaction, Friedel-Crafts reaction, Diels-Alder reaction, transfer hydrogenation reaction and the like. For example, be applied to the transfer hydrogenation reaction of 2-phenylquinoline and Hantzsch ethyl ester: 0.2mol% catalyst consumption, benzene is made solvent, reacts 11 hours under room temperature, can obtain quantitative yield and enantiomeric excess of 98% ( ee); and under the same conditions, the phosphoric acid reaction is faster than that of the corresponding H 8 -BINOL and BINOL skeleton, and the conversion rate increases up to 35% and 20%, respectively.
附图说明 Description of drawings
图1为(R)-7,7'-二溴-5,5'-联四氢萘酮-6,6'-二酚(3)的单晶X-射线衍射图。 Figure 1 is a single crystal X-ray diffraction pattern of (R)-7,7'-dibromo-5,5'-binethalone-6,6'-diol (3).
图2为(R)-7,7'-二苯基-5,5'-联四氢萘酮-6,6'-二酚-磷酸(11)的单晶X-射线衍射图。 Fig. 2 is a single crystal X-ray diffraction pattern of (R)-7,7'-diphenyl-5,5'-tetralone-6,6'-diphenol-phosphoric acid (11).
图3为(R)-7,7'-二[3,5-二(三氟甲基)-苯基]-5,5'-联四氢萘酮-6,6'-二酚-磷酸(12)的单晶X-射线衍射图。 Figure 3 is (R)-7,7'-bis[3,5-bis(trifluoromethyl)-phenyl]-5,5'-tetralone-6,6'-diphenol-phosphoric acid Single crystal X-ray diffraction pattern of (12).
图4为(R)-7,7'-二(2,4,6-三异丙基苯基)-5,5'-联四氢萘酮-6,6'-二酚-磷酸(13)的单晶X-射线衍射图。 Figure 4 is (R)-7,7'-bis(2,4,6-triisopropylphenyl)-5,5'-tetralone-6,6'-diphenol-phosphoric acid (13 ) single crystal X-ray diffraction pattern.
具体实施方式 Detailed ways
通过下述的实施例,有助于理解本发明,但并不限制本发明的内容。以下所述仅是本发明的优选具体实施方式,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。实施例中的反应条件同样适用于未提及的另一种对映异构体及其外消旋体。 The following examples help to understand the present invention, but do not limit the content of the present invention. The following description is only a preferred embodiment of the present invention, for those of ordinary skill in the art, without departing from the principle of the present invention, some improvements and modifications can also be made, and these improvements and modifications should also be considered Be the protection scope of the present invention. The reaction conditions in the examples apply equally to the other enantiomer not mentioned and to its racemate.
下述实施例中所使用的实验方法如无特殊说明,均为常规方法。其所用的材料、试剂等,如无特殊说明,均可从商业途径得到。 The experimental methods used in the following examples are conventional methods unless otherwise specified. The materials and reagents used therein can be obtained from commercial sources unless otherwise specified.
实施例1、(R)-5,5'-联四氢萘酮-6,6'-二酚(2)的制备 Embodiment 1, the preparation of (R)-5,5'-tetralone-6,6'-diol (2)
反应方程式如上式所示,其中,DDQ为2,3-二氯-5,6-二氰基-1,4-苯醌; The reaction equation is shown in the above formula, wherein, DDQ is 2,3-dichloro-5,6-dicyano-1,4-benzoquinone;
500mL单口瓶中称入(R)-H8-BINOL(4.42g,15.0mmol),加入100mL1,4-二氧六环和5mLH2O搅拌溶解。冰浴下加入DDQ(13.62g,60.0mmol)。25℃反应4小时后,抽滤,50mL1,4-二氧六环洗涤滤渣。将滤液浓缩,加入200mL乙酸乙酯,饱和Na2SO3溶液洗涤三次。无水Na2SO4干燥有机相,抽滤,浓缩,直接投下一步。也可通过硅胶柱层析提纯(石油醚:乙酸乙酯,体积比2:1~1:2),得白色固体。熔点263~264℃;[α]D 20=+129.2(c0.48,MeOH);IR(film)3164,2945,1648,1571,1274,1186cm-1;1HNMR(400MHz,MeOD)δ7.98(d,J=8.8Hz,2H),6.90(d,J=8.8Hz,2H),5.50(s,2H),2.67-2.53(m,6H),2.49-2.38(m,2H),2.09-1.91(m,4H);13CNMR(100MHz,MeOD)δ199.0,160.2,146.7,128.8,125.1,121.6,113.8,38.1,26.8,22.8;HRMS(ESI)CalcdforC20H19O4(M+H):323.1278;Found:323.1278. Weigh (R)-H 8 -BINOL (4.42g, 15.0mmol) into a 500mL single-necked bottle, add 100mL 1,4-dioxane and 5mLH 2 O and stir to dissolve. DDQ (13.62 g, 60.0 mmol) was added under ice cooling. After reacting at 25°C for 4 hours, filter with suction, and wash the filter residue with 50 mL of 1,4-dioxane. Concentrate the filtrate, add 200 mL of ethyl acetate, and wash with saturated Na 2 SO 3 solution three times. The organic phase was dried over anhydrous Na 2 SO 4 , filtered with suction, concentrated, and directly sent to the next step. It can also be purified by silica gel column chromatography (petroleum ether: ethyl acetate, volume ratio 2:1 ~ 1:2) to obtain a white solid. Melting point 263~264℃; [α] D 20 =+129.2(c0.48, MeOH); IR (film) 3164, 2945, 1648, 1571, 1274, 1186cm -1 ; 1 HNMR (400MHz, MeOD) δ7.98 (d,J=8.8Hz,2H),6.90(d,J=8.8Hz,2H),5.50(s,2H),2.67-2.53(m,6H),2.49-2.38(m,2H),2.09- 1.91 (m, 4H); 13 CNMR (100MHz, MeOD) δ199.0, 160.2, 146.7, 128.8, 125.1, 121.6, 113.8, 38.1, 26.8, 22.8; HRMS (ESI) Calcd for C 20 H 19 O 4 (M+H): 323.1278; Found: 323.1278.
实施例2、(R)-7,7'-二溴-5,5'-联四氢萘酮-6,6'-二酚(3)的制备 Example 2, the preparation of (R)-7,7'-dibromo-5,5'-tetralone-6,6'-diol (3)
25℃水浴下,250mL单口瓶中加入100mL1,4-二氧六环,搅拌下加入HBr(48%aq)(7.5mL,66.0mmol),然后5分钟内滴加H2O2(35%aq)(3.7mL,42.9mmol),再加入上一步的产物。反应1小时后,加入0.95gNa2SO3溶于25mL水的溶液,搅拌半小时,用10%NaOH水溶液调节pH至8~9,用乙酸乙酯洗三次。用6mol/L稀盐酸将水相酸化至pH1~2,乙酸乙酯萃取,无水Na2SO4干燥,抽滤,浓缩,硅胶柱层析(石油醚:乙酸乙酯,体积比3:1~3:2),得4.90g浅黄色固体产物,两步收率合计68%。熔点280~281℃;[α]D 20=+83.0(c0.42,MeOH);IR(film)3281,2947,1662,1560,1231,1189cm-1;1HNMR(400MHz,MeOD)δ8.23(s,2H),2.59(t,J=6.4Hz,4H),2.55-2.33(m,4H),2.10-1.95(m,4H);13CNMR(100MHz,MeOD)δ197.4,156.3,145.4,132.1,126.6,122.6,109.5,37.8,26.6,22.5;HRMS(ESI)CalcdforC20H17Br2O4(M+H):478.9488;Found:478.9490.化合物(3)的单晶X-射线衍射图见附图1. In a water bath at 25°C, add 100mL of 1,4-dioxane to a 250mL single-necked bottle, add HBr (48%aq) (7.5mL, 66.0mmol) under stirring, and then add H 2 O 2 (35%aq ) (3.7mL, 42.9mmol), and the product from the previous step was added. After reacting for 1 hour, add a solution of 0.95g Na 2 SO 3 dissolved in 25 mL water, stir for half an hour, adjust the pH to 8-9 with 10% NaOH aqueous solution, and wash with ethyl acetate three times. Use 6mol/L dilute hydrochloric acid to acidify the aqueous phase to pH 1~2, extract with ethyl acetate, dry over anhydrous Na2SO4 , filter with suction, concentrate, and perform silica gel column chromatography (petroleum ether: ethyl acetate, volume ratio 3:1 ~3:2), 4.90 g of light yellow solid product was obtained, and the total yield of the two steps was 68%. Melting point 280~281℃; [α] D 20 =+83.0(c0.42, MeOH); IR (film) 3281, 2947, 1662, 1560, 1231, 1189cm -1 ; 1 HNMR (400MHz, MeOD) δ8.23 (s,2H),2.59(t,J=6.4Hz,4H),2.55-2.33(m,4H),2.10-1.95(m,4H); 13 CNMR(100MHz,MeOD)δ197.4,156.3,145.4,132.1 , 126.6, 122.6, 109.5, 37.8, 26.6, 22.5; HRMS (ESI) CalcdforC 20 H 17 Br 2 O 4 (M+H): 478.9488; Found: 478.9490. The single crystal X-ray diffraction pattern of compound (3) is shown in Attachment 1.
实施例3、(R)-7,7'-二苯基-5,5'-联四氢萘酮-6,6'-二酚(4)的制备 Example 3, the preparation of (R)-7,7'-diphenyl-5,5'-bitetralone-6,6'-diol (4)
反应方程式如上式所示,其中,Ac为乙酰基;Ph为苯基;nBu为正丁基;Ad为金刚烷基;DME为乙二醇二甲醚; The reaction equation is as shown in the above formula, wherein Ac is acetyl; Ph is phenyl; nBu is n -butyl; Ad is adamantyl; DME is ethylene glycol dimethyl ether;
在氩气保护下向反应器中依次加入化合物(R)-3(5.0g,10.46mmol),苯硼酸(4.46g,36.61mmol),醋酸钯(0.0472g,0.21mmol),二(金刚烷基)正丁基膦(0.094g,0.262mmol),90mL乙二醇二甲醚和45mL1.0mol/L碳酸钾溶液。将反应器放入95℃油浴搅拌。11小时后停止加热,冷却至室温,加入50mL饱和氯化铵溶液,冰浴下1.6mol/L稀盐酸酸化至pH3~4,静置2小时,抽滤(得到滤液1)。滤饼溶于二氯甲烷/甲醇,无水Na2SO4干燥,抽滤,浓缩至快干,抽滤(得到滤液2),滤饼用石油醚洗涤,得4.08g灰色固体产品。滤液1用二氯甲烷萃取,无水Na2SO4干燥,抽滤,与滤液2合并浓缩后硅胶柱层析(石油醚:乙酸乙酯,体积比4:1~2:1),得另一批产品0.68g,总产率95%。熔点300~301℃;[α]D 20=+36.5(c0.51,EtOAc);IR(film)3296,2945,1664,1582,1233,1181cm-1;1HNMR(400MHz,DMSO-d6)δ9.03(s,2H),7.88(s,2H),7.56(d,J=7.2Hz,4H),7.46(t,J=7.2Hz,4H),7.36(t,J=7.6Hz,2H),2.63-2.32(m,8H),2.04-1.88(m,4H);13CNMR(100MHz,DMSO-d6)δ196.9,157.2,145.7,138.5,129.6,128.7,128.4,127.5,126.1,122.4,38.5,27.3,23.0;HRMS(ESI)CalcdforC32H27O4(M+H):475.1904;Found:475.1903. Under argon protection, compound (R)-3 (5.0g, 10.46mmol), phenylboronic acid (4.46g, 36.61mmol), palladium acetate (0.0472g, 0.21mmol), bis(adamantyl ) n-butylphosphine (0.094g, 0.262mmol), 90mL ethylene glycol dimethyl ether and 45mL 1.0mol/L potassium carbonate solution. The reactor was placed in a 95°C oil bath and stirred. Stop heating after 11 hours, cool to room temperature, add 50 mL of saturated ammonium chloride solution, acidify to pH 3-4 with 1.6 mol/L dilute hydrochloric acid in ice bath, let stand for 2 hours, and filter with suction (obtain filtrate 1). The filter cake was dissolved in dichloromethane/methanol, dried over anhydrous Na 2 SO 4 , filtered with suction, concentrated to quick dryness, filtered with suction (to obtain filtrate 2), and washed with petroleum ether to obtain 4.08 g of a gray solid product. The filtrate 1 was extracted with dichloromethane, dried over anhydrous Na 2 SO 4 , filtered with suction, combined with the filtrate 2 and concentrated, followed by silica gel column chromatography (petroleum ether:ethyl acetate, volume ratio 4:1~2:1), and another One batch of product is 0.68g, and the total yield is 95%. Melting point 300~301℃; [α] D 20 =+36.5(c0.51, EtOAc); IR(film) 3296, 2945, 1664, 1582, 1233, 1181cm -1 ; 1 HNMR(400MHz, DMSO-d 6 ) δ9.03(s,2H),7.88(s,2H),7.56(d,J=7.2Hz,4H),7.46(t,J=7.2Hz,4H),7.36(t,J=7.6Hz,2H ),2.63-2.32(m,8H),2.04-1.88(m,4H); 13 CNMR(100MHz,DMSO-d 6 )δ196.9,157.2,145.7,138.5,129.6,128.7,128.4,127.5,126.1,122.4, 38.5, 27.3, 23.0; HRMS (ESI) Calcd for C 32 H 27 O 4 (M+H): 475.1904; Found: 475.1903.
实施例4、(R)-7,7'-二[3,5-二(三氟甲基)-苯基]-5,5'-联四氢萘酮-6,6'-二酚(5)的制备 Example 4, (R)-7,7'-bis[3,5-bis(trifluoromethyl)-phenyl]-5,5'-tetralone-6,6'-diphenol ( 5) Preparation
反应方程式如上式所示,其中,Ac为乙酰基,nBu为正丁基;Ad为金刚烷基;DME为乙二醇二甲醚; The reaction equation is shown in the above formula, wherein Ac is acetyl, nBu is n -butyl; Ad is adamantyl; DME is ethylene glycol dimethyl ether;
在氩气保护下向反应器中依次加入化合物(R)-3(3.62g,7.6mmol),3,5-二(三氟甲基)苯硼酸(5.88g,22.8mmol),醋酸钯(0.0342g,0.152mmol),二(金刚烷基)正丁基膦(0.0682g,0.190mmol),80mL乙二醇二甲醚和40mL1.0mol/L碳酸钾溶液。将反应器放入95℃油浴搅拌。9小时后停止加热,冷却至室温,加入40mL饱和氯化铵溶液,冰浴下3mol/L稀盐酸酸化至pH3~4,乙酸乙酯萃取,无水Na2SO4干燥,抽滤,浓缩后硅胶柱层析(石油醚:乙酸乙酯,体积比5:1~3:1),得产品为浅褐色固体5.11g,产率90%。熔点189~190℃;[α]D 20=+6.9(c0.32,THF);IR(film)3280,2944,1657,1559,1276,1125cm-1;1HNMR(400MHz,MeOD)δ8.23(s,4H),8.17(s,2H),7.96(s,2H),2.71-2.59(m,6H),2.59-2.49(m,2H),2.18-2.01(m,4H);13CNMR(100MHz,MeOD)δ198.4,157.4,147.4,140.5,131.1(q,JC-F=32.9Hz),130.2,129.5,126.2,125.6,123.6(q,JC-F=270.2Hz),121.1,120.3,37.9,27.0,22.6;HRMS(ESI)CalcdforC36H23F12O4(M+H):747.1399;Found:747.1381. Under argon protection, compound (R)-3 (3.62g, 7.6mmol), 3,5-bis(trifluoromethyl)phenylboronic acid (5.88g, 22.8mmol), palladium acetate (0.0342 g, 0.152mmol), di(adamantyl) n-butylphosphine (0.0682g, 0.190mmol), 80mL ethylene glycol dimethyl ether and 40mL 1.0mol/L potassium carbonate solution. The reactor was placed in a 95°C oil bath and stirred. Stop heating after 9 hours, cool to room temperature, add 40mL saturated ammonium chloride solution, acidify to pH 3~4 with 3mol/L dilute hydrochloric acid in ice bath, extract with ethyl acetate, dry with anhydrous Na 2 SO 4 , filter with suction, and concentrate Silica gel column chromatography (petroleum ether: ethyl acetate, volume ratio 5:1-3:1), the product was light brown solid 5.11g, yield 90%. Melting point 189~190℃; [α] D 20 =+6.9(c0.32,THF); IR(film)3280,2944,1657,1559,1276,1125cm -1 ; 1 HNMR(400MHz,MeOD)δ8.23 (s,4H),8.17(s,2H),7.96(s,2H),2.71-2.59(m,6H),2.59-2.49(m,2H),2.18-2.01(m,4H); 13 CNMR( 100MHz,MeOD)δ198.4,157.4,147.4,140.5,131.1(q,J CF =32.9Hz),130.2,129.5,126.2,125.6,123.6(q,J CF =270.2Hz),121.1,120.3,37.9,27.0, 22.6; HRMS (ESI) Calcd for C 36 H 23 F 12 O 4 (M+H): 747.1399; Found: 747.1381.
实施例5、(R)-7,7'-二(2,4,6-三异丙苯基)-5,5'-联四氢萘酮-6,6'-二甲醚(7)的制备 Example 5, (R)-7,7'-bis(2,4,6-triisopropylphenyl)-5,5'-tetralone-6,6'-dimethyl ether (7) preparation of
反应方程式如上式所示,其中,Me为甲基;iPr为异丙基;Ac为乙酰基; The reaction equation is as shown in the above formula, wherein, Me is a methyl group; i Pr is an isopropyl group; Ac is an acetyl group;
水浴时,向化合物6(3.257g,4.48mmol)的25mL冰醋酸悬浊液中,缓慢滴加三氧化铬(2.688g,26.88mmol)的冰醋酸/水(10mL,体积比3:1)溶液,15分钟滴完。室温反应24小时,加入碎冰,10%NaOH中和,二氯甲烷萃取,饱和NaHCO3洗涤,无水Na2SO4干燥,抽滤,浓缩后硅胶柱层析(石油醚:乙酸乙酯,体积比19:1),得浅黄色固体0.77g,产率23%。熔点284~285℃;[α]D 20=+2.45(c0.245,CH2Cl2);IR(film)2960,1679,1589,1459,1222cm-1;1HNMR(400MHz,CDCl3)δ7.92(s,2H),7.05(s,2H),7.04(s,2H),3.17(s,6H),2.99-2.86(m,2H),2.75-2.59(m,10H),2.59-2.46(m,2H),2.17-2.06(m,4H),1.30(d,J=7.2Hz,12H),1.19(d,J=6.8Hz,6H),1.14-1.06(m,18H);13CNMR(100MHz,CDCl3)δ197.8,159.8,148.8,146.8,146.7,143.9,132.5,131.6,131.1,129.1,128.4,121.1,121.0,59.5,39.1,34.5,31.2,31.0,27.5,25.6,25.4,24.32,24.28,23.6,23.4,23.3;HRMS(ESI)CalcdforC50H67O4(M+H):755.5034;Found:755.5027. In a water bath, slowly add a solution of chromium trioxide (2.688g, 26.88mmol) in glacial acetic acid/water (10mL, volume ratio 3:1) dropwise to compound 6 (3.257g, 4.48mmol) in 25mL of glacial acetic acid suspension , dripped in 15 minutes. React at room temperature for 24 hours, add crushed ice, neutralize with 10% NaOH, extract with dichloromethane, wash with saturated NaHCO 3 , dry with anhydrous Na 2 SO 4 , filter with suction, concentrate and perform silica gel column chromatography (petroleum ether: ethyl acetate, Volume ratio 19:1), 0.77 g of light yellow solid was obtained, yield 23%. Melting point 284~285℃; [α] D 20 =+2.45(c0.245, CH 2 Cl 2 ); IR (film) 2960, 1679, 1589, 1459, 1222 cm -1 ; 1 HNMR (400MHz, CDCl 3 ) δ7 .92(s,2H),7.05(s,2H),7.04(s,2H),3.17(s,6H),2.99-2.86(m,2H),2.75-2.59(m,10H),2.59-2.46 (m,2H),2.17-2.06(m,4H),1.30(d,J=7.2Hz,12H),1.19(d,J=6.8Hz,6H),1.14-1.06(m,18H); 13 CNMR (100MHz, CDCl 3 )δ197.8, 159.8, 148.8, 146.8, 146.7, 143.9, 132.5, 131.6, 131.1, 129.1, 128.4, 121.1, 121.0, 59.5, 39.1, 34.5, 31.2, 31.0, 25.5, 24.6, 2 24.28, 23.6, 23.4, 23.3; HRMS (ESI) Calcd for C 50 H 67 O 4 (M+H): 755.5034; Found: 755.5027.
实施例6、(R)-7,7'-二(2,4,6-三异丙苯基)-5,5'-联四氢萘酮-6,6'-二酚(8)的制备 Example 6, (R)-7,7'-bis(2,4,6-triisopropylphenyl)-5,5'-tetralone-6,6'-diol (8) preparation
反应方程式如上式所示,其中,Me为甲基;iPr为异丙基;Et为乙基;DMF为N,N-二甲基甲酰胺; The reaction equation is shown in the above formula, wherein Me is methyl; i Pr is isopropyl; Et is ethyl; DMF is N,N-dimethylformamide;
化合物7(0.755g,1.0mmol),NaSEt(0.504g,6.0mmol)的5mLDMF混合物在130℃反应10小时。冷却至室温,2mL饱和NH4Cl淬灭,5%稀盐酸酸化至pH3~4,乙酸乙酯萃取,饱和食盐水洗涤有机相,无水Na2SO4干燥,抽滤,浓缩后硅胶柱层析(石油醚:乙酸乙酯,体积比10:1~7:1),得浅黄色固体0.615g,产率85%。熔点314~316℃;[α]D 20=+11.9(c0.42,CH2Cl2);IR(film)3278,2958,1665,1598,1556,1228,1181cm-1;1HNMR(400MHz,CDCl3)δ7.94(s,2H),7.12(d,J=1.2Hz,2H),7.10(d,J=1.6Hz,2H),5.05(s,2H),2.99-2.87(m,2H),2.72-2.52(m,12H),2.17-2.07(m,4H),1.30(d,J=6.8Hz,12H),1.16(d,J=6.8Hz,6H),1.11(d,J=6.8Hz,6H),1.06(d,J=6.8Hz,6H),0.98(d,J=6.8Hz,6H);13CNMR(100MHz,CDCl3)δ197.6,155.6,150.2,148.6,148.4,145.1,130.2,128.2,126.7,125.6,121.9,121.8,120.5,39.0,34.6,30.9,30.8,27.3,24.39,24.36,24.26,24.22,24.19,24.0,23.3;HRMS(ESI)CalcdforC50H63O4(M+H):727.4721;Found:727.4716. Compound 7 (0.755g, 1.0mmol), a mixture of NaSEt (0.504g, 6.0mmol) in 5mL DMF was reacted at 130°C for 10 hours. Cool to room temperature, quench with 2mL saturated NH 4 Cl, acidify to pH 3-4 with 5% dilute hydrochloric acid, extract with ethyl acetate, wash the organic phase with saturated brine, dry with anhydrous Na 2 SO 4 , filter with suction, and concentrate on silica gel column Analysis (petroleum ether: ethyl acetate, volume ratio 10:1-7:1) gave 0.615 g of light yellow solid with a yield of 85%. Melting point 314~316℃; [α] D 20 =+11.9(c0.42, CH 2 Cl 2 ); IR(film) 3278,2958,1665,1598,1556,1228,1181cm -1 ; 1 HNMR(400MHz, CDCl 3 )δ7.94(s,2H),7.12(d,J=1.2Hz,2H),7.10(d,J=1.6Hz,2H),5.05(s,2H),2.99-2.87(m,2H ),2.72-2.52(m,12H),2.17-2.07(m,4H),1.30(d,J=6.8Hz,12H),1.16(d,J=6.8Hz,6H),1.11(d,J= 6.8Hz, 6H), 1.06(d, J=6.8Hz, 6H), 0.98(d, J=6.8Hz, 6H); 13 CNMR(100MHz, CDCl 3 ) δ197.6, 155.6, 150.2, 148.6, 148.4, 145.1, 130.2, 128.2, 126.7, 125.6, 121.9, 121.8, 120.5, 39.0, 34.6, 30.9, 30.8, 27.3, 24.39, 24.36, 24.26, 24.22, 24.19, 24.0, 23.3; HRMS (ESI) CalcdforC 504 HM 63 +H):727.4721; Found:727.4716.
实施例7、(R)-7,7'-二三苯基硅基-5,5'-联四氢萘酮-6,6'-二酚(10)的制备 Example 7, Preparation of (R)-7,7'-bistriphenylsilyl-5,5'-bistetralone-6,6'-diol (10)
氩气保护下向反应器中依次加入化合物9(2.92g,3.6mmol),DDQ(4.91g,21.6mmol),FeCl2·4H2O(0.146g,0.73mmol),1,2-二氯乙烷(29mL),THF(9mL)和水(1.3mL)。将反应器放入30℃油浴搅拌。13小时后停止加热,冷却至室温,加入40mL饱和NH4Cl溶液,NaHSO3(0.5g),无水MgSO4干燥,抽滤,浓缩后硅胶柱层析(石油醚:乙酸乙酯,体积比9:1-4:1),得产品为白色固体1.232g,产率40%。熔点189-190℃;[α]D 20=+42.4(c0.33,CH2Cl2);IR(film)3276,3068,2945,1675,1555,1428,1232,1108cm-1;1HNMR(400MHz,CDCl3)δ8.16(s,2H),7.60-7.53(m,12H),7.47-7.41(m,6H),7.39-7.32(m,12H),5.47(s,2H),2.62-2.45(m,8H),2.10-1.96(m,4H);13CNMR(100MHz,CDCl3)δ196.5,162.8,148.3,140.0,136.4,133.3,130.2,128.3,127.3,119.9,118.4,38.7,27.6,23.0;HRMS(ESI)CalcdforC56H47O4Si2(M+H):839.3007;Found:839.3000. Under argon protection, compound 9 (2.92g, 3.6mmol), DDQ (4.91g, 21.6mmol), FeCl 2 · 4H 2 O (0.146g, 0.73mmol), 1,2-dichloroethane were sequentially added to the reactor. alkanes (29 mL), THF (9 mL) and water (1.3 mL). The reactor was placed in a 30°C oil bath and stirred. Stop heating after 13 hours, cool to room temperature, add 40mL saturated NH 4 Cl solution, NaHSO 3 (0.5g), anhydrous MgSO 4 Dry, suction filter, silica gel column chromatography after concentration (petroleum ether: ethyl acetate, volume ratio 9:1-4:1), the product obtained was 1.232 g of white solid, and the yield was 40%. Melting point 189-190°C; [α] D 20 =+42.4 (c0.33, CH 2 Cl 2 ); IR (film) 3276, 3068, 2945, 1675, 1555, 1428, 1232, 1108cm -1 ; 1 HNMR ( 400MHz, CDCl 3 )δ8.16(s,2H),7.60-7.53(m,12H),7.47-7.41(m,6H),7.39-7.32(m,12H),5.47(s,2H),2.62- 2.45(m,8H),2.10-1.96(m,4H); 13 CNMR(100MHz,CDCl 3 )δ196.5,162.8,148.3,140.0,136.4,133.3,130.2,128.3,127.3,119.9,118.4,38.7,27.6, 23.0; HRMS (ESI) Calcd for C 56 H 47 O 4 Si 2 (M+H): 839.3007; Found: 839.3000.
实施例8、(R)-7,7'-二苯基-5,5'-联四氢萘酮-6,6'-二酚-磷酸(11)的制备 Example 8, Preparation of (R)-7,7'-diphenyl-5,5'-binethalone-6,6'-diphenol-phosphoric acid (11)
反应方程式如上式所示,其中,Ph为苯基;Py为吡啶; The reaction equation is as shown in the above formula, wherein, Ph is phenyl; Py is pyridine;
氩气保护下,在4(2.0g,4.21mmol)的12mL吡啶溶液中缓慢滴加三氯氧磷(1.94g,12.63mmol),回流反应12小时。冷却至室温,缓慢滴加水(12mL),回流反应5小时。冷却至室温,加入80mL3mol/L稀盐酸,二氯甲烷萃取,无水Na2SO4干燥,抽滤,浓缩,硅胶柱层析(二氯甲烷:甲醇,体积比19:1~13:1),含产物组份的淋洗剂溶液合并后,200mL1mol/L稀盐酸洗涤,无水Na2SO4干燥,抽滤,浓缩得白色固体1.65g,产率73%。熔点289~291℃;[α]D 20=-86.6(c0.33,THF);IR(film)3385,2938,1678,1259,1230,1100cm-1;1HNMR(400MHz,DMSO-d6)δ8.03(s,2H),7.74(d,J=7.2Hz,4H),7.46(t,J=7.4Hz,4H),7.39(t,J=7.2Hz,2H),3.04-2.88(m,2H),2.80-2.58(m,4H),2.56-2.39(m,2H),2.17-2.03(m,2H),2.00-1.86(m,2H);13CNMR(100MHz,DMSO-d6)δ197.1,150.7,150.6,145.1,136.8,132.9,132.8,129.9,129.7,128.7,128.1,127.6,38.7,27.8,23.3;31PNMR(162MHz,DMSO-d6)δ-2.39;HRMS(ESI)CalcdforC32H26O6P(M+H):537.1462;Found:537.1456.化合物(11)的单晶X-射线衍射图见附图2. Under argon protection, phosphorus oxychloride (1.94 g, 12.63 mmol) was slowly added dropwise to a solution of 4 (2.0 g, 4.21 mmol) in 12 mL of pyridine, and the reaction was refluxed for 12 hours. After cooling to room temperature, water (12 mL) was slowly added dropwise, and the reaction was refluxed for 5 hours. Cool to room temperature, add 80mL3mol/L dilute hydrochloric acid, extract with dichloromethane, dry over anhydrous Na2SO4 , filter with suction, concentrate, and perform silica gel column chromatography (dichloromethane:methanol, volume ratio 19:1~13:1) , and the eluent solutions containing the product components were combined, washed with 200 mL of 1mol/L dilute hydrochloric acid, dried over anhydrous Na 2 SO 4 , filtered with suction, and concentrated to obtain 1.65 g of a white solid with a yield of 73%. Melting point 289~291℃; [α] D 20 =-86.6(c0.33, THF); IR(film) 3385, 2938, 1678, 1259, 1230, 1100cm -1 ; 1 HNMR(400MHz, DMSO-d 6 ) δ8.03(s, 2H), 7.74(d, J=7.2Hz, 4H), 7.46(t, J=7.4Hz, 4H), 7.39(t, J=7.2Hz, 2H), 3.04-2.88(m ,2H),2.80-2.58(m,4H),2.56-2.39(m,2H),2.17-2.03(m,2H),2.00-1.86(m,2H); 13 CNMR(100MHz,DMSO-d 6 ) δ197.1, 150.7, 150.6, 145.1, 136.8, 132.9, 132.8, 129.9, 129.7, 128.7, 128.1, 127.6, 38.7, 27.8, 23.3; 31 PNMR (162MHz, DMSO-d 6 ) δ-2.39; HRMS (ESI) CalcdforC H 26 O 6 P(M+H):537.1462; Found:537.1456. The single crystal X-ray diffraction pattern of compound (11) is shown in Figure 2.
实施例9、(R)-7,7'-二[3,5-二(三氟甲基)-苯基]-5,5'-联四氢萘酮-6,6'-二酚-磷酸(12)的制备 Example 9, (R)-7,7'-bis[3,5-bis(trifluoromethyl)-phenyl]-5,5'-tetralone-6,6'-diphenol- Preparation of phosphoric acid (12)
反应方程式如上式所示,其中,Py为吡啶; The reaction equation is as shown in the above formula, wherein, Py is pyridine;
氩气保护下,在5(0.25g,0.335mmol)的1.0mL吡啶溶液中缓慢滴加三氯氧磷(0.1027g,0.67mmol),70℃反应3小时后冷却至室温,缓慢滴加水(0.5mL),70℃反应2小时。冷却至室温,依次加入15mL二氯甲烷和15mL1mol/L稀盐酸,水相用二氯甲烷萃取,合并有机相,无水Na2SO4干燥,抽滤,浓缩,硅胶柱层析(二氯甲烷:甲醇,体积比20:1~10:1),含产物组份的淋洗剂溶液合并后,50mL1mol/L稀盐酸洗涤,无水Na2SO4干燥,抽滤,浓缩得白色固体0.2251g,产率83%。熔点>320℃;[α]D 20=-16.7(c0.39,THF);IR(film)3441,2948,1683,1279,1132cm-1;1HNMR(400MHz,DMSO-d6)δ8.66(s,4H),8.12(s,2H),8.09(s,2H),3.05-2.92(m,2H),2.81-2.58(m,4H),2.54-2.42(m,2H),2.17-2.02(m,2H),1.98-1.85(m,2H);13CNMR(100MHz,DMSO-d6)δ197.0,152.6(d,JC-P=9Hz),146.2,139.9,131.2,130.5(q,JC-F=33Hz),130.0,129.8,129.3,128.2,123.9(q,JC-F=271Hz),121.5,38.7,27.9,23.3;31PNMR(162MHz,DMSO-d6)δ-0.23;HRMS(ESI)CalcdforC36H22F12O6P(M+H):809.0957;Found:809.0948.化合物(12)的单晶X-射线衍射图见附图3. Under the protection of argon, phosphorus oxychloride (0.1027g, 0.67mmol) was slowly added dropwise to a solution of 5 (0.25g, 0.335mmol) in 1.0mL of pyridine, reacted at 70°C for 3 hours, cooled to room temperature, and slowly added dropwise with water (0.5 mL), react at 70°C for 2 hours. Cool to room temperature, add 15 mL of dichloromethane and 15 mL of 1mol/L dilute hydrochloric acid successively, extract the aqueous phase with dichloromethane, combine the organic phases, dry over anhydrous Na2SO4 , filter with suction, concentrate, and perform silica gel column chromatography (dichloromethane : Methanol, volume ratio 20:1~10:1), after the eluent solutions containing product components were combined, washed with 50mL1mol/L dilute hydrochloric acid, dried over anhydrous Na2SO4 , suction filtered, and concentrated to give 0.2251g of white solid , yield 83%. Melting point>320℃; [α] D 20 =-16.7(c0.39,THF); IR(film)3441,2948,1683,1279,1132cm -1 ; 1 HNMR(400MHz,DMSO-d 6 )δ8.66 (s,4H),8.12(s,2H),8.09(s,2H),3.05-2.92(m,2H),2.81-2.58(m,4H),2.54-2.42(m,2H),2.17-2.02 (m,2H),1.98-1.85(m,2H); 13 CNMR(100MHz,DMSO-d 6 )δ197.0,152.6(d,J CP =9Hz),146.2,139.9,131.2,130.5(q,J CF = 33Hz), 130.0, 129.8, 129.3, 128.2, 123.9 (q, J CF = 271Hz), 121.5, 38.7, 27.9, 23.3; 31 PNMR (162MHz, DMSO-d 6 ) δ-0.23; HRMS (ESI) CalcdforC 36 H 22 F 12 O 6 P(M+H): 809.0957; Found: 809.0948. The single crystal X-ray diffraction pattern of compound (12) is shown in Figure 3.
实施例10、(R)-7,7'-二(2,4,6-三异丙基苯基)-5,5'-联四氢萘酮-6,6'-二酚-磷酸(13)的制备 Example 10, (R)-7,7'-bis(2,4,6-triisopropylphenyl)-5,5'-tetralone-6,6'-diphenol-phosphoric acid ( 13) Preparation
反应方程式如上式所示,其中,iPr为异丙基;Py为吡啶; The reaction equation is as shown in the above formula, wherein, i Pr is isopropyl; Py is pyridine;
氩气保护下,在8(0.60g,0.83mmol)的3.0mL吡啶溶液中缓慢滴加三氯氧磷(0.382g,2.49mmol),回流反应5小时后冷却至室温,缓慢滴加水(3.0mL),回流反应3小时。冷却至室温,加入20mL3mol/L稀盐酸,二氯甲烷萃取,无水Na2SO4干燥,抽滤,浓缩,硅胶柱层析(二氯甲烷:甲醇,体积比40:1~30:1),含产物组份的淋洗剂溶液合并后,100mL1mol/L稀盐酸洗涤,无水Na2SO4干燥,抽滤,浓缩得灰白色固体0.59g,产率90%。熔点303~304℃;[α]D 20=-113.5(c0.37,THF);IR(film)3439,2959,1690,1460,1362,1222cm-1;1HNMR(400MHz,DMSO-d6)δ7.78(s,2H),7.11(d,J=1.2Hz,2H),7.04(d,J=1.2Hz,2H),3.02-2.85(m,4H),2.78-2.62(m,6H),2.54-2.38(m,4H),2.22-2.09(m,2H),2.09-1.97(m,2H),1.25(d,J=6.8Hz,12H),1.18-1.05(m,18H),0.86(d,J=6.8Hz,6H);13CNMR(100MHz,DMSO-d6)δ197.0,151.1(d,JC-P=9Hz),148.5,147.6,146.6,144.8,131.4,130.9(d,JC-P=6Hz),130.9,129.7,126.8,121.4,120.5,38.6,34.0,31.0,30.7,27.4,26.6,24.9,24.5,24.4,23.7,23.3,23.2;31PNMR(162MHz,DMSO-d6)δ-2.71;HRMS(ESI)CalcdforC50H62O6P(M+H):789.4279;Found:789.4265.化合物(13)的单晶X-射线衍射图见附图4. Under the protection of argon, slowly drop phosphorus oxychloride (0.382g, 2.49mmol) in 3.0mL pyridine solution of 8 (0.60g, 0.83mmol), cool to room temperature after reflux reaction for 5 hours, slowly add water (3.0mL ), reflux reaction for 3 hours. Cool to room temperature, add 20mL 3mol/L dilute hydrochloric acid, extract with dichloromethane, dry over anhydrous Na 2 SO 4 , filter with suction, concentrate, and perform silica gel column chromatography (dichloromethane:methanol, volume ratio 40:1~30:1) , and the eluent solutions containing the product components were combined, washed with 100 mL of 1 mol/L dilute hydrochloric acid, dried over anhydrous Na 2 SO 4 , filtered with suction, and concentrated to obtain 0.59 g of off-white solid with a yield of 90%. Melting point 303~304℃; [α] D 20 =-113.5(c0.37, THF); IR(film) 3439, 2959, 1690, 1460, 1362, 1222cm -1 ; 1 HNMR(400MHz, DMSO-d 6 ) δ7.78(s,2H),7.11(d,J=1.2Hz,2H),7.04(d,J=1.2Hz,2H),3.02-2.85(m,4H),2.78-2.62(m,6H) ,2.54-2.38(m,4H),2.22-2.09(m,2H),2.09-1.97(m,2H),1.25(d,J=6.8Hz,12H),1.18-1.05(m,18H),0.86 (d, J = 6.8Hz, 6H); 13 CNMR (100MHz, DMSO-d 6 ) δ197.0, 151.1 (d, J CP = 9Hz), 148.5, 147.6, 146.6, 144.8, 131.4, 130.9 (d, J CP = 6Hz),130.9,129.7,126.8,121.4,120.5,38.6,34.0,31.0,30.7,27.4,26.6,24.9,24.5,24.4,23.7,23.3,23.2; 31 PNMR(162MHz,DMSO-d 6 )δ-2.71 ; HRMS (ESI) CalcdforC 50 H 62 O 6 P (M+H): 789.4279; Found: 789.4265. The single crystal X-ray diffraction pattern of compound (13) is shown in accompanying drawing 4.
实施例11、(R)-7,7'-三苯基硅基-5,5'-联四氢萘酮-6,6'-二酚-磷酸(14)的制备 Example 11, Preparation of (R)-7,7'-triphenylsilyl-5,5'-tetralone-6,6'-diphenol-phosphoric acid (14)
氩气保护下,在化合物10(0.616g,0.734mmol)的3mL吡啶溶液中缓慢滴加三氯氧磷(0.2mL,16.56mmol),回流反应12小时。冷却至室温,缓慢滴加水(3mL),回流反应5小时。冷却至室温,加入20mL3mol/L稀盐酸,二氯甲烷萃取,无水Na2SO4干燥,抽滤,浓缩,硅胶柱层析(二氯甲烷:甲醇,体积比19:1-13:1),含产物组份的淋洗剂溶液合并后,50mL1mol/L稀盐酸洗涤,无水Na2SO4干燥,抽滤,浓缩得白色固体0.38g,产率54%。熔点227-228℃;[α]D 20=-155.0(c0.305,CH2Cl2);IR(film)3376,2925,1685,1545,1428,1234,1108cm-1;1HNMR(400MHz,DMSO-d6)δ8.03(s,2H),7.52-7.46(m,12H),7.45-7.39(m,6H),7.39-7.32(m,12H),3.00-2.86(m,2H),2.73-2.53(m,4H),2.48-2.36(m,2H),2.14-2.01(m,2H),1.98-1.85(m,2H);13CNMR(100MHz,DMSO-d6)δ197.1,158.8,158.7,148.0,138.3,136.6,134.1,130.0,129.1,128.2,126.8,124.5,124.5,38.6,27.8,22.9,21.5;31PNMR(162MHz,DMSO-d6)δ-4.50;HRMS(ESI)CalcdforC56H45NaO6PSi2(M+Na):923.2384;Found:923.2386. Under argon protection, phosphorus oxychloride (0.2 mL, 16.56 mmol) was slowly added dropwise to a solution of compound 10 (0.616 g, 0.734 mmol) in 3 mL of pyridine, and the reaction was refluxed for 12 hours. After cooling to room temperature, water (3 mL) was slowly added dropwise, and the reaction was refluxed for 5 hours. Cool to room temperature, add 20 mL of 3mol/L dilute hydrochloric acid, extract with dichloromethane, dry over anhydrous Na 2 SO 4 , filter with suction, concentrate, and perform silica gel column chromatography (dichloromethane:methanol, volume ratio 19:1-13:1) , and eluent solutions containing product components were combined, washed with 50 mL of 1mol/L dilute hydrochloric acid, dried over anhydrous Na 2 SO 4 , filtered with suction, and concentrated to obtain 0.38 g of a white solid with a yield of 54%. Melting point 227-228°C; [α] D 20 =-155.0 (c0.305, CH 2 Cl 2 ); IR (film) 3376, 2925, 1685, 1545, 1428, 1234, 1108cm -1 ; 1 HNMR (400MHz, DMSO-d 6 )δ8.03(s,2H),7.52-7.46(m,12H),7.45-7.39(m,6H),7.39-7.32(m,12H),3.00-2.86(m,2H), 2.73-2.53(m,4H),2.48-2.36(m,2H),2.14-2.01(m,2H),1.98-1.85(m,2H); 13 CNMR(100MHz,DMSO-d 6 )δ197.1,158.8, 5 _ _ H 45 NaO 6 PSi 2 (M+Na): 923.2384; Found: 923.2386.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510543647.3A CN105111228A (en) | 2015-08-28 | 2015-08-28 | Chiral phosphoric acid with 5,5'-bitetralone skeleton and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510543647.3A CN105111228A (en) | 2015-08-28 | 2015-08-28 | Chiral phosphoric acid with 5,5'-bitetralone skeleton and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105111228A true CN105111228A (en) | 2015-12-02 |
Family
ID=54659379
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510543647.3A Pending CN105111228A (en) | 2015-08-28 | 2015-08-28 | Chiral phosphoric acid with 5,5'-bitetralone skeleton and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105111228A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106883162A (en) * | 2017-03-09 | 2017-06-23 | 华东师范大学 | The double indoles of one class chirality (S)/(R) 1,1 ' simultaneously [a] binaphthol derivative and preparation method |
CN117623954A (en) * | 2023-10-20 | 2024-03-01 | 南通大学 | A kind of binaphthyl ketone chiral luminescent material and its preparation method and application |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101812046A (en) * | 2010-02-26 | 2010-08-25 | 中国科学院上海有机化学研究所 | 1,4-oxa-compound, furan compound, synthetic method and applications |
CN102781888A (en) * | 2009-09-30 | 2012-11-14 | 麻省理工学院 | Highly Z-selective olefin metathesis |
-
2015
- 2015-08-28 CN CN201510543647.3A patent/CN105111228A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102781888A (en) * | 2009-09-30 | 2012-11-14 | 麻省理工学院 | Highly Z-selective olefin metathesis |
CN101812046A (en) * | 2010-02-26 | 2010-08-25 | 中国科学院上海有机化学研究所 | 1,4-oxa-compound, furan compound, synthetic method and applications |
Non-Patent Citations (4)
Title |
---|
MAGNUS RUEPING ET AL.: "Synthesis and Structural Aspects of N-Triflylphosphoramides and Their Calcium Salts—Highly Acidic and Effective Brønsted Acids", 《CHEM. EUR. J.》 * |
NISHANT V. SEWGOBIND ET AL.: "Enantioselective BINOL-Phosphoric Acid Catalyzed Pictet-Spengler Reactions of N-Benzyltryptamine", 《J. ORG. CHEM.》 * |
TETSU TSUBOGO ET AL.: "Highly Enantioselective Friedel–Crafts–type Alkylation Reactions of Indoles with Chalcone Derivatives using a Chiral Barium Catalyst", 《CHEM. ASIAN J.》 * |
苏亚军等: "手性磷酸在不对称反应中的应用", 《有机化学》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106883162A (en) * | 2017-03-09 | 2017-06-23 | 华东师范大学 | The double indoles of one class chirality (S)/(R) 1,1 ' simultaneously [a] binaphthol derivative and preparation method |
CN117623954A (en) * | 2023-10-20 | 2024-03-01 | 南通大学 | A kind of binaphthyl ketone chiral luminescent material and its preparation method and application |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN115650916B (en) | A method for synthesizing spiro-substituted acridine compounds and their application | |
CN105111228A (en) | Chiral phosphoric acid with 5,5'-bitetralone skeleton and preparation method thereof | |
CN103145769B (en) | Bis-cyclometallated compound of heteronuclear ruthenium palladium and its preparation method and application | |
CN111468183A (en) | Polyfluorinated triaryl chiral spirophosphoric acid catalyst and preparation method and use thereof | |
CN103012502B (en) | Heteronuclear iridium gold bicyclo metal compound as well as preparation method and application of compound | |
CN113234099B (en) | Photochemical synthesis method of alkyl borate compound | |
CN101676293B (en) | Bisglyoxaline organic phosphine compound and preparation method thereof | |
JP2010059159A (en) | 2,2',6,6'-tetrahydroxy-3,3',5,5'-tetrasubstituted biphenyl ligand and method for synthesizing the same | |
CN108299486A (en) | A method of cyclopropylboronic acid ester compounds are prepared based on iron catalysis | |
CN113651738A (en) | A kind of preparation method of phenylene sulfide compound | |
CN100415755C (en) | 2,2',6,6'-tetrasubstituted nitrogen phosphine ligand and its synthesis method | |
CN103242379B (en) | 2-ferrocenyl-aryl quinoline and preparation method thereof | |
CN116003360A (en) | Preparation method for synthesizing orange compounds from carbon dioxide and alkyne | |
CN107383097A (en) | The preparation method of the phosphonylation derivative of the ketone of 3 benzylidene iso-indoles of N phenyl 1 | |
CN114308121A (en) | Phosphine oxide catalyst and its preparation method and application | |
CN108864173B (en) | Process for converting substituted sodium aryl sulfinate to aryl tri-n-butyl tin | |
CN113980044B (en) | Preparation method of Ir-O-P type catalyst diboronic acid/ester compound | |
CN110746462A (en) | Efficient synthesis method of dendritic cyclotriphosphazene compound | |
CN114085173B (en) | A kind of preparation method of 2-nitro-4-methylsulfonylbenzaldehyde | |
CN115650824B (en) | Chiral diol and preparation method thereof, prepared catalyst and preparation method and application thereof | |
CN102432425B (en) | Preparation method of 1,3-disubstituted-3-aryl propylene compound and application thereof | |
CN115093313B (en) | Multi-methyl substituted spiroindane derivative cyclopentadiene, rhodium complex, preparation method, intermediate and application thereof | |
CN101648977B (en) | 2,2',6,6'site connected 1,1'-diphenyl axially chiral bi-phosphoramide and phosphorous acid ester ligand and preparation method thereof | |
CN103012503B (en) | Heteronuclear palladium iridium bicyclo metal compound as well as preparation method and application of compound | |
EP4471039A1 (en) | Cyclopropane skeleton monophosphine ligand and palladium complex thereof as well as preparation method and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
AD01 | Patent right deemed abandoned |
Effective date of abandoning: 20190409 |
|
AD01 | Patent right deemed abandoned |